Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Canna Law Blog

SEPTEMBER 24, 2022

Given the expansive and stratified plans for New York’s adult-use cannabis industry (with the general ban on vertical integration, emphasis on social equity and advanced conditional licenses), the Director of Policy will have a quite a few responsibilities. First, the OCM clearly was looking for someone with a background in data analytics.

Policy 72

Policy Research and Development Data Legislation 72

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

FEBRUARY 23, 2022

Provides a conditional adult-use cultivator license to process and distribute cannabis flower products without holding an adult-use processor or distributor license; provides a conditional adult-use processor license to process and distribute cannabis products; provides for the repeal of certain provisions upon the expiration thereof.

Legislation 105

Legislation Conditions Cultivation Agriculture 105

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

The Joint Blog

JUNE 8, 2020

We continue to explore and report on new cannabis related university and certification programs that are popping up around the world to help meet the demand of employment for the sector. Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. And much more!

Programs 32

Programs Research and Development Environment Packaging 32

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. And the process of adding additional conditions was often lengthy, difficult and mired in paternalism.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc. About Cybin.

Research and Development 52

Research and Development Safety Media Data 52

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

JULY 28, 2021

Andy served as University of Alberta Associate Vice President (Research) and was a member of the Scientific Advisory Board of the CIHR Institute of Neuroscience Mental Health & Addiction from 2012-2016. With his research and insight, Dr. Greenshaw has held many roles within the greater community.

Research and Development 105

Research and Development Events Media Data 105

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. Many individuals are becoming more cautious about the long-term use of prescription pain medications due to concerns about dependency and the risk of developing opioid use disorder.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Veriheal

NOVEMBER 22, 2021

Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. Headset’s data shows that medical cannabis consumers tend to spend more money in order to purchase a larger supply at one time.

Recreational 98

Recreational Data Dispensary Cannabis 98

Cannabis Law Report

NOVEMBER 15, 2021

a manufacturer of LinearDNA™ via PCR for nucleic acid therapeutics and diagnostics, today announced the receipt of repeat orders from diagnostic customers and a first Contract Research Organization (CRO) order from a new biotherapeutic customer, a federally funded research and development laboratory focused on cancer research.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

NOVEMBER 9, 2021

Pavel Otáhal, contributing author and Head of the Gene Immunotherapy Research Department at ÚHKT, stated, “Our study compares the manufacture of CAR19 T-cells via PCR-made transposon DNA (LinearDNA) with mRNA encoding of the transposase against a conventional plasmid approach. Dr. James A. About LineaRx, Inc.,

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

SpeedWeed

SEPTEMBER 17, 2021

“Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

AUGUST 29, 2021

Aureus branded products are cultivated, extracted, and manufactured by Avicanna ’s subsidiaries in Colombia where they benefit from optimal environmental conditions to produce cannabinoid active pharmaceutical ingredients economically and sustainably and include a range of extracts of CBD, THC and rare cannabinoids such as CBG.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. s (CSE: MXT) (OTC: MXTTF) SHAMAN and YMI programs apply machine learning to high-resolution health records to better diagnose mental health disorders. Building the Data Backend.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Program between St. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention. Cannabis research has been limited up to this point due to its status as a Schedule 1 controlled substance.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

JULY 29, 2021

Aureus branded products are cultivated, extracted, and manufactured by Avicanna’s subsidiaries in Colombia where they benefit from optimal environmental conditions to produce cannabinoid active pharmaceutical ingredients economically and sustainably and include a range of extracts of CBD, THC and rare cannabinoids such as CBG.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

AUGUST 11, 2021

Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Cannabis Law Report

OCTOBER 29, 2021

Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. The Abstract is as follows. 006) and lower odds of diabetes in the past year (adjusted odds ratio (aOR)?=?0.88

Research and Development 52

Research and Development Treatment Data Conditions 52

Cannabis Law Report

JULY 25, 2022

Medical marijuana is only legal for those who suffer from a qualifying medical condition. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. You must make sure that your condition qualifies and go through the application process. .

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Cannabis Law Report

MARCH 21, 2022

Employee assistance program. Who We Are: Schwazze (OTCQX: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Employee assistance program.

Business 52

Business Seed-To-Sale Research and Development Conditions 52

Cannabis Law Report

JUNE 7, 2021

NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. 1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. Dr. James A.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

JULY 9, 2021

As we begin design of Phase 2 of our buildout, we will add more square feet to our facilities to continue to meet the demand of the medical program in West Virginia.”. Forward-looking statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments.

Research and Development 105

Research and Development Cultivation Seed-To-Sale Dispensary 105

Greenspoon Marder Cannabis Law Group Blog

AUGUST 7, 2019

The Department of Agriculture’s Agriculture Research Service (USDA-ARS) will oversee the development and will co-locate at Cornell AgriTech. The facility currently maintains seeds and performs research and development on crops like grapes, apples, cherries and Brassica. government in the 1980s. Boor, the Ronald P.

Banking 53

Banking Hemp Research and Development Supply Chain 53